The overlap syndrome: combination of the autoimmune hepatitis with the primary biliary cholangitis
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 1
Abstract
The overlap syndrome in hepatology traditionally defined as the simultaneous presence in a patient of clinical or laboratory signs of two different autoimmune liver diseases. The most common combination is autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). In this case, a differential diagnosis based on clinical signs is often difficult. Routine laboratory tests indicate the presence of both parenchymal and cholestatic variants of liver damage. There are no international criteria that clearly define the case of overlap syndrome. There is a set of descriptive criteria presented by the International Group for the Study of Autoimmune Hepatitis (IAIHG), which includes not only biochemical and serological indicators, but also the histological examination of the liver. Usually, in the case of overlap syndrome, the course of the liver disease is more aggressive. For example, in case of combination of PBC and AIH, severe fibrosis is more frequent at the time of diagnosis, hepatocellular insufficiency develops faster and indications for liver transplantation appear earlier. The management of patients with overlap syndrome in each case is individual and focused on the prevailing component: autoimmune hepatitis or primary biliary cholangitis. The feasibility of combined immunosuppressive therapy and ursodeoxycholic acid (UDCA) has not been completely clarified. Moreover, this applies both to individual publications and to the consensus documents of the International Group for the Study of Autoimmune Hepatitis. In the absence of a sustained response in the case of a combination therapy, tactics may be revised in favor of monotherapy with UDCA, given the high percentage of complications with continued treatment with immunosuppressants.
Authors and Affiliations
O. Ye. Zaytseva, S. L. Kushnir, O. O. Diadyk
Keywords
Related Articles
- EP ID EP508487
- DOI 10.30978/MG-2019-1-71
- Views 151
- Downloads 0
Changes in the microcrystallization of oral fluid in the dynamics of treatment of catarrhal gingivitis in adolescents with chronic gastroduodenitis
Objective — to study the changes of microcrystallization of saliva in adolescents with chronic gastroduodenitis in the process of complex treatment of generalized catarrhal gingivitis. Materials and methods. The type of...
Influence of non-alcoholic fatty liver disease on the cardiac hemodynamics indices and vascular disorders in patients with essential hypertension
Objective — to compare the structural and functional state of the heart, vessels and liver in patients with isolated EH and in conditions of its combination with NAFLD. Materials and methods. A total of 117 patients wit...
The dynamics of results of the esophageal 24-hour multichannel intraluminal impedance-pH monitoring in patients with stable angina and gastroesophageal reflux disease against the background of the basic treatment correction
Due to the mutual aggravating effects in the comorbidity of the stable angina of effort (SAE) and gastroesophageal reflux disease (GERD), the necessity arises for the correction of basic therapy of each of these patholog...
Gastrointestinal lesions in patients, administrated acetylsalicylic acid for cardiovascular pathology: the syndromic diagnosis and possible methods of correction
Objective — to determine the effects of acetylsalicylic acid (ASA) preparations on the development of gastrointestinal tract lesions and to assess their severity depending on the use of PPIs, with the help of GSRS questi...
Mechanisms of formation of the gastroesophageal reflux disease and coronary heart disease comorbidity
Objective — to identify possible transnosological mechanisms for the formation of comorbidity of gastroesophageal reflux disease (GERD) and coronary heart disease (CHD). Materials and methods. The study involved patients...